Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450138 · ClinicalTrials.gov registry record · Phase 1
Open Label, Phase I ZD6474 Head and Neck Cancer Study
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00450138 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 48 participants.
The verdict
NCT00450138, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.
Interventions
- DRUG Cisplatin
- RADIATION Radiation
- DRUG ZD6474 (vandetanib)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450138
The ClinicalTrials.gov registry entry for NCT00450138 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT00450138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450138 about?
NCT00450138 is a clinical study titled "Open Label, Phase I ZD6474 Head and Neck Cancer Study". The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.
What is the current status of trial NCT00450138?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2006-12. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00450138?
The interventions under investigation include: Cisplatin (DRUG), Radiation (RADIATION), ZD6474 (vandetanib) (DRUG).
Who is sponsoring clinical trial NCT00450138?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.